Renal parameters | |
---|---|
Sodium | 135–145 mmol/L |
Potassium | 3.2–4.7 mmol/L |
Bicarbonate | 22–29 mmol/L |
Chloride | 95–105 mmol/L |
Urea | 15–40 mg/dL |
Creatinine | 0.7–1.4 mg/dL (male) 0.5–1.1 mg/dL (female) |
Bone profile | |
Calcium | 8.3–10.4 mg/dL |
Albumin | 3.5–5.0 g/dL |
Phosphate | 2.5–4.6 mg/dL |
Alkaline phosphatase | 40–125 U/L |
Vitamin D [25(OH)D] | > 30 ng/mL |
Parathyroid hormone | 8–74 pg/mL |
24-hour urinary calcium | 50–300 mg/24 hr |
24-hour urinary phosphate | 400–1300 mg/24 hr |
Lipid profile | |
Total cholesterol | < 160 mg/dL |
Triglyceride | < 150 mg/dL |
LDL cholesterol | < 100 mg/dL |
HDL cholesterol | > 40 mg/dL |
Liver function tests (LFT) | |
Bilirubin total | 0.5–1 mg/dL |
Bilirubin direct | 0.1–0.5 mg/dL |
Protein | 6.0–8.5 g/dL |
Albumin | 3.5–5.0 g/dL |
Alanine aminotransferase (ALT or SGPT) | 5–40 U/L |
Aspartate aminotransferase (AST or SGOT) | 8–40 U/L |
Alkaline phosphatase | 40–125 U/L |
Diabetes | ||
---|---|---|
Glucose | ||
Fasting (AC) | Normal | 70–100 mg/dL |
Impaired fasting glucose | 100–125 mg/dL | |
Diabetes mellitus | ≥ 126 mg/dL | |
2-hour post meal(PC) | Normal | < 140 mg/dL |
Impaired glucose tolerance | 140–199 mg/dL | |
Diabetes mellitus | ≥ 200 mg/dL | |
HbA1c | ||
Normal | < 5.7% | |
Pre-diabetes | 5.7–6.4% | |
Diabetes | ≥ 6.5% | |
C -Peptide | 1.1–5.0 ng/mL | |
Anti-glutamic acid decarboxylase (GAD) antibody | < 5.0 U/mL | |
Anti-islet cell antibody | < 7.5 U/mL | |
Insulin (fasting) | 0–30 μIμ/mL | |
Urine microalbumin | < 30 mg/gCr | < 20 mg/min |
Urine protein/creatinine | < 0.35 mg/mg | |
24-hour urine protein | 50–150 mg/24 hr |
Hormone assays | |
---|---|
Thyroid | |
Total thyroxine (TT4) | 4.5–12.5 μg/dL |
Free thyroxine (FT4) | 0.8–2.0 ng/dL |
Total T3 | 90–190 ng/dL |
Thyroid stimulating hormone (TSH) | 0.3–4.5 mIU/L |
Thyroid antibodies | |
| < 50 IU/mL |
| < 100 IU/mL |
Thyroglobulin (Post-thyroidectomy) | < 1 ng/mL |
Calcitonin | 0–50 pg/mL |
Adrenal | |
17 OH-progesterone | |
Men | 0.4–3.3 ng/mL |
Women (Follicular phase) | 0.1–1.2 ng/mL |
(Luteal phase) | 0.4–4.8 ng/mL |
Dehydroepiandrosterone sulphate (DHEAS) | |
Men | 80–560 μg/dL |
Women | 35–430 μg/dL |
Plasma renin activity (PRA) | |
Supine | 0.05–2.3 ng/mL/h |
Upright | 1.3–4.0 ng/mL/h |
Aldosterone | |
Supine | 10–160 pg/mL |
Upright | 40–310 pg/mL |
Urine metanephrine | < 350 mg/day |
Urine normetanephrine | < 600 mg/day |
Pituitary | |
Human growth hormone (Basal) | 0–5.0 ng/mL |
| < 0.6 ng/mL |
| < 0.6 ng/mL |
Insulin like growth factor-1 (IGF-1) | |
| 88–452 ng/mL |
| 127–424 ng/mL |
| 117–329 ng/mL |
| 94–252 ng/mL |
| 69–200 ng/mL |
Adrenocorticotrophic hormone (ACTH) | 0–46 pg/mL |
Cortisol | |
| 7–25 μg/dL |
| > 20 μg/dL |
| < 1.8 μg/dL |
24-hour urinary free cortisol (UFC) | 0–50 μg/24 hrs |
Gonadal Hormones | |
Follicle stimulating hormone (FSH) (women) | |
Follicular phase | 3.9–10 mIU/mL |
Mid-cycle | 6.6–29 mIU/mL |
Luteal phase | 2.3–8 mIU/mL |
Postmenopausal | 26–139 mIU/mL |
Men | 1.7–11 mIU/mL |
Luteinizing hormone (LH) (women) | |
Follicular phase | 0.5–18 mIU/mL |
Mid-cycle | 15–80 mIU/mL |
Luteal phase | 0.5–18 mIU/mL |
Postmenopausal | 16–64 mIU/mL |
Men | 0.5–10 mIU/mL |
Estradiol | |
Follicular phase | 0–0.587 nmol/L |
Luteal phase | 0.1–0.91 nmol/L |
Progesterone | |
Follicular phase | 1.00–3.80 nmol/L |
Mid-cycle | 1.70–50 nmol/L |
Luteal phase | 2.30–56.60 nmol/L |
Prolactin | |
Women | 1.9–25.0 ng/mL |
Men | 2.5–17 ng/mL |
Testosterone | |
Women | 50–120 ng/dL |
Men (20–49 years) | 270–1030 ng/dL |
(> 50 years) | 212–755 ng/dL |
Sex hormone binding globulin (SHBG) | |
Women | 26.1–110 nmol/L |
Men | 14.5–48.4 nmol/L |